Advertisement
UK markets closed

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     

  • AIM

    755.28
    +2.16 (+0.29%)
     

  • GBP/EUR

    1.1676
    +0.0019 (+0.16%)
     

  • GBP/USD

    1.2488
    -0.0023 (-0.19%)
     

  • Bitcoin GBP

    51,007.36
    -570.16 (-1.11%)
     

  • CMC Crypto 200

    1,324.80
    -71.73 (-5.13%)
     

  • S&P 500

    5,110.09
    +61.67 (+1.22%)
     

  • DOW

    38,299.35
    +213.55 (+0.56%)
     

  • CRUDE OIL

    83.89
    +0.32 (+0.38%)
     

  • GOLD FUTURES

    2,346.10
    +3.60 (+0.15%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,161.01
    +243.73 (+1.36%)
     

  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Allscripts Healthcare Solutions (MDRX) Jumps: Stock Rises 7%

Zacks Equity Research
Updated

Allscripts Healthcare Solutions, Inc. MDRX was a big mover last session, as its shares rose a little over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.61 to $12.30 in the past one-month time frame.

Over the last 30 days, the company witnessed two negative estimate revisions while the Zacks Consensus Estimate also moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Allscripts Healthcare Solutions currently carries a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Allscripts Healthcare Solutions, Inc. Price

 

Allscripts Healthcare Solutions, Inc. Price | Allscripts Healthcare Solutions, Inc. Quote

ADVERTISEMENT

A better-ranked stock in the Medical Info Systems space is Medidata Solutions, Inc. MDSO, sporting a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is MDRX going up? Or down? Predict to see what others think: Up or Down

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Medidata Solutions, Inc. (MDSO): Free Stock Analysis Report
 
Allscripts Healthcare Solutions, Inc. (MDRX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research